A detailed history of Stratos Wealth Partners, Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 3,940 shares of MRNA stock, worth $145,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,940
Previous 3,649 7.97%
Holding current value
$145,189
Previous $433,000 39.26%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$63.64 - $125.14 $18,519 - $36,415
291 Added 7.97%
3,940 $263,000
Q2 2024

Jul 24, 2024

SELL
$101.21 - $166.61 $206,772 - $340,384
-2,043 Reduced 35.89%
3,649 $433,000
Q1 2024

Apr 16, 2024

BUY
$85.37 - $115.44 $46,697 - $63,145
547 Added 10.63%
5,692 $606,000
Q4 2023

Jan 24, 2024

SELL
$69.51 - $104.43 $78,268 - $117,588
-1,126 Reduced 17.96%
5,145 $511,000
Q3 2023

Oct 24, 2023

SELL
$96.41 - $126.61 $162,836 - $213,844
-1,689 Reduced 21.22%
6,271 $647,000
Q2 2023

Jul 18, 2023

BUY
$118.5 - $160.53 $214,603 - $290,719
1,811 Added 29.45%
7,960 $967,000
Q1 2023

Apr 27, 2023

SELL
$135.66 - $197.02 $127,791 - $185,592
-942 Reduced 13.28%
6,149 $944,000
Q4 2022

Jan 19, 2023

BUY
$118.38 - $210.04 $7,221 - $12,812
61 Added 0.87%
7,091 $0
Q3 2022

Oct 24, 2022

SELL
$118.07 - $194.18 $262,823 - $432,244
-2,226 Reduced 24.05%
7,030 $831,000
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $60,439 - $91,120
-516 Reduced 5.28%
9,256 $1.32 Million
Q1 2022

Apr 26, 2022

BUY
$126.46 - $235.05 $133,541 - $248,212
1,056 Added 12.12%
9,772 $1.68 Million
Q4 2021

Jan 14, 2022

SELL
$225.82 - $368.51 $1.48 Million - $2.42 Million
-6,557 Reduced 42.93%
8,716 $2.21 Million
Q3 2021

Oct 19, 2021

SELL
$221.9 - $484.47 $496,612 - $1.08 Million
-2,238 Reduced 12.78%
15,273 $5.88 Million
Q2 2021

Jul 19, 2021

BUY
$129.91 - $234.98 $32,867 - $59,449
253 Added 1.47%
17,511 $4.12 Million
Q1 2021

Apr 27, 2021

BUY
$109.18 - $185.98 $4,476 - $7,625
41 Added 0.24%
17,258 $2.26 Million
Q4 2020

Jan 29, 2021

BUY
$65.74 - $169.86 $399,567 - $1.03 Million
6,078 Added 54.57%
17,217 $1.8 Million
Q3 2020

Oct 29, 2020

BUY
$54.34 - $94.85 $175,463 - $306,270
3,229 Added 40.82%
11,139 $788,000
Q2 2020

Jul 28, 2020

BUY
$29.67 - $80.0 $234,689 - $632,800
7,910 New
7,910 $508,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.